Did You Know?

Editor’s Picks

Latest News

FACT’s New Standards for Immune Effector Cells in the Community Clinical Setting Help Bring Cell Therapies Closer to Patients

Consensus-Built ‘Fit-for-Purpose' Quality and Safety Standards for Community Oncology Programs OMAHA, NEBRASKA / ACCESS Newswire / November 10, 2025 /...

FACT’s New Standards for Immune Effector Cells in the Community Clinical Setting Help Bring Cell Therapies Closer to Patients

Consensus-Built ‘Fit-for-Purpose' Quality and Safety Standards for Community Oncology Programs OMAHA, NEBRASKA / ACCESS Newswire / November 10, 2025 /...

Ontada Presents Framework for Accelerating Clinical Development with Real-World External Control Arms in Phase 2 Trials at ISPOR

The novel framework is designed to help accelerate clinical development through more efficient and informative early-stage trialsBOSTON--(BUSINESS WIRE)--Ontada®, a leader...

The National Children’s Cancer Society (NCCS) Announces New Mission and Vision Statements Reflecting Its Continued Commitment to Families Impacted by Childhood Cancer

The National Children's Cancer Society (NCCS), a leading nonprofit dedicated to supporting children with cancer, their families, and survivors, has...

BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter’s Option to Purchase Additional Shares

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 10, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...

error: Content is protected !!